139009-66-8

Basic information

• Product Name: (S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID
• Synonyms: (S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID;(S)-N-Boc-2,2-diMethyloxazolidine-4-carboxylic Acid
• CAS NO: 139009-66-8
• Molecular Formula: C₁₁H₁₉NO₅
• Molecular Weight: 245.27
• Mol File: 139009-66-8.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID(139009-66-8)
• EPA Substance Registry System: (S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID(139009-66-8)

Safety Data

• Hazardous Substances Data: 139009-66-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
(S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID is used as a protective group in peptide synthesis for preventing unwanted peptide bond formation. This is particularly important in the development of new drugs and therapeutic agents, where precise control over the synthesis process is crucial for achieving the desired molecular structure and biological activity.
Used in Chemical Synthesis Processes:
In chemical synthesis processes that require the use of protective groups, (S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID is used as a temporary blocking agent to protect reactive amine groups. This allows for more controlled and selective reactions, leading to the production of complex molecules with specific properties and functions.

Upstream product

• 3262-72-4 (S)-N-(tert-butoxycarbonyl)serine 
• 77-76-9 2,2-dimethoxy-propane 
• 59524-02-6 N-tert-butoxycarbonyl-L-serine benzyl ester 
• 2766-43-0 N-tert-butyloxycarbonyl-L-serine methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 95715-86-9 (S)-2,2-dimethyl-oxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl ester 

Downstream Products

• 95715-86-9 (S)-2,2-dimethyl-oxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl ester 
• 221526-47-2 1,1-dimethylethyl (4S)-4-[(RS)-[(3RS)-3-benzenesulfonyl-2-oxopiperidin-3-yl]hydroxymethyl]-2,2-dimethyloxazolidine-3-carboxylate 
• 1048350-53-3 (R)-2,2-dimethyl-4-phenylaminomethyloxazolidine-3-carboxylic acid tert-butyl ester 
• 221526-48-3 4-(1-benzenesulfonyl-2-oxo-piperidin-3-ylidenemethyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 221526-49-4 1,1-dimethylethyl (4R)-4-[(3RS)-1-benzenesulfonyl-2-oxopiperidin-3-yl]methyl-2,2-dimethyloxazolidine-3-carboxylate 
• 221526-50-7 1,1-dimethylethyl (4R)-4-[1-benzenesulfonyl-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]methyl-2,2-dimethyloxazolidine-3-carboxylate 
• 593288-88-1 1,1-dimethylethyl (4R)-4-[(1RS)-1-benzenesulfonyl-2-oxo-3-phenylthiopiperidin-3-yl]methyl-2,2-dimethyloxazolidine-3-carboxylate 
• 115822-55-4 (4S,1'S)-4-(1'-benzyloxy-2'-oxoethyl)-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 
• 115843-62-4 (S)-4-((S)-Benzyloxy-thiazol-2-yl-methyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 102308-32-7 (4S)-4-formyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 122709-21-1 (4S)-2,2-Dimethyl-4-(N-methoxy-N-methylcarbamoyl)oxazolidin-3-carbonsaeure-(tert-butyl)ester 

Relevant articles and documents

Efficient construction of a doubly functionalized trisoxazole derivative relevant to the synthesis of the novel telomerase inhibitor telomestatin and its analogues

An efficient construction of a suitably functionalized trisoxazole derivative related to telomestatin was developed from L-serine, which involved three sequential oxazoline cyclization-oxidation steps in an overall yield of 11% in a linear sequence of twelve steps. Georg Thieme Verlag Stuttgart.

Capturing Intermediates in the Reaction Catalyzed by NosN, a Class C Radical S-Adenosylmethionine Methylase Involved in the Biosynthesis of the Nosiheptide Side-Ring System

Nosiheptide is a ribosomally synthesized and post-translationally modified thiopeptide natural product that possesses antibacterial, anticancer, and immunosuppressive properties. It contains a bicyclic structure composed of a large macrocycle and a unique

Capturing Intermediates in the Reaction Catalyzed by NosN, a Class C Radical S-Adenosylmethionine Methylase Involved in the Biosynthesis of the Nosiheptide Side-Ring System

Nosiheptide is a ribosomally synthesized and post-translationally modified thiopeptide natural product that possesses antibacterial, anticancer, and immunosuppressive properties. It contains a bicyclic structure composed of a large macrocycle and a unique

[4-(1, 3, 3-TRIMETHYL-2-OXO-3, 4-DIHYDRO-1H-QUINOXALIN-7-YL) PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF

The present invention relates to a novel [4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or a salt thereof. The compound or a salt thereof of the present invention has a glucocorticoid receptor agonist activity, and is u

Total synthesis of the azolemycins

The first total syntheses of newly isolated polyazole natural products azolemycins A-D, along with the synthesis of the tetra-oxazole non-natural analogue, are described.

BROMODOMAIN-INHIBITING COMPOUNDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING A CANCER

Provided is a novel compound having bromodomain and extra terminal domain (BET) protein inhibiting activities, and a pharmaceutical composition comprising the same which can be useful for prevention or treatment of precancerous transformation or cancer.

Hepatitis C Virus Inhibitors

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

Total synthesis and biological activity of natural product Urukthapelstatin A

Herein we report the first total synthesis of the natural product Urkuthaplestatin A (Ustat A) utilizing a convergent synthetic strategy. The characterization and biological activity match those of the previously published natural product. Interestingly,

A convenient procedure for the preparation of Garner's aldehyde

The palladium/silane reduction of a serine thioester derivative allows for the preparation of enantiomerically pure Garner's aldehyde from serine, in gram quantities within 24 h.